Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
29 Apr 2021
UCB's General Meeting of Shareholders 2021
Read More
28 Apr 2021
UCB Announces PDUFA Date for Bimekizumab
Read More
23 Apr 2021
Acquisitions of own shares and disposals of own shares
Read More
23 Apr 2021
UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
Read More
23 Apr 2021
The New England Journal of Medicine Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis
Read More
22 Apr 2021
UCB’s zilucoplan shows no relevant effect in immune-mediated necrotizing myopathy (IMNM)
Read More
20 Apr 2021
Acquisitions of own shares and Disposals of own shares
Read More
16 Apr 2021
UCB showcases new research at the 73rd American Academy of Neurology Annual Meeting to demonstrate broad neurology leadership and future portfolio
Read More
14 Apr 2021
Notice of Early Redemption - €350 million € 1.875% fixed rate notes due 2 April 2022
Read More
9 Apr 2021
Acquisitions of own shares and Disposals of own shares
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
5
Page
6
Page
7
Page
8
Current page
9
Page
10
Page
11
Page
12
Page
13
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss